期刊文献+

3种免疫学方法对肺炎球菌结合物及其中间品的多糖抗原性研究 被引量:3

Study on the antigenicity of Streptococcus pneumonia polysaccharide, its derivatives and conjugates by three immunological assays
原文传递
导出
摘要 目的:对肺炎球菌结合物及其制备过程中间品进行多种方法抗原性监控,以期对肺炎球菌结合物制备过程中多糖抗原性进行差异分析,进而为制备工艺参数的选择提供重要参考指标。方法用已建立的免疫双扩散法、抑制ELISA、速率比浊法对23 F型肺炎球菌结合物制备过程中间品和结合物进行抗原性分析;对不同方法结果比较、综合分析23 F型肺炎球菌结合物制备过程中的多糖抗原性变化。结果建立分析抗原性变化的抑制ELISA和速率比浊法;3种方法均可用于肺炎球菌结合物制备过程中的多糖抗原性分析;其中抑制ELISA可监控制备过程中抗原性的微小改变并可量化。结论用多种方法对23 F型肺炎球菌结合物制备过程中的多糖抗原性进行分析,为结合物制备过程中多糖抗原性的监控提供了多层面的有效方法,并为抗原性监控提供可量化的方法。 Objective To monitor and analyze the antigenicity of Streptococcus pneumonia polysaccharide, its derivatives and conjugates by three immunological assays .Methods Inhibition ELISA and rate nephelometry(RN) were established for this study.Antigenicity of serotype 23F pneumococcal conjugates and their intermediates were analyzed by double immunodiffusion assay , inhibition ELISA and RN .The results derived from three assays were comparatively analyzed to evaluate the changes of antigenicity during the preparing process of serotype 23F conjugate.Results Double immunodiffusion assay, inhibition ELISA and RN were all applicable to antigenicity analysis during the process of conjugate preparation .Inhibition ELISA could quantitatively detect a slight difference of polysaccharide antigenicity during the preparing process . Conclusion The antigenicity of polysaccharide during the preparing process of pneumococcal conjugates could be analytically monitored by using three immunological assays .This study provided evidence for successfully using immunological assays as the quality control means during the preparing process of pneumococcal conjugates .
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2014年第6期471-475,共5页 Chinese Journal of Microbiology and Immunology
基金 国家科技部科技重大专项课题(2011ZX09401-403) 十二五国家高技术发展研究计划(863计划)(2012AA02A401) 2012年甘肃省战略性新兴产业专项项目(甘发改高技[2012]672号) 2009年国家科技支撑计划项目(2008BAI66B01)
关键词 肺炎球菌结合物 抑制ELISA 抗原性 免疫双扩散法 速率比浊法 Streptococcus pneumococcal conjugate Inhibition ELISA Antigenicity Double immunodiffusion Rate nephelometry
  • 相关文献

参考文献8

  • 1Poland GA. The burden of pneumoeoceal disease : the role of con- jugate vaccines[J]. Vaccine, 1999, 17(13-14) : 1674-1679.
  • 2张云,舒俭德.肺炎球菌性肺炎及其疫苗[J].中华流行病学杂志,2002,23(1):78-78. 被引量:14
  • 3Fritzell, B. Epidemiology of invasive pneumoeoceal disease in Eu- rope[J]. J Current Therapeutic research, 2002, 63 (Suppl 1 ) : 3-9.
  • 4Prevention of pneumococcal disease : recommendations of the Advi- sory Committee on Immunization Practices (ACIP) [ J ]. MMWR Recomm Rep, 1997, 46 (RR-8) : 1-24.
  • 5Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccha- ride conjugate vaccine[J]. N Engl J Med, 2003, 348 (18) : 1737-1746.
  • 6Jergensen CS, Christiansen M, Nergaard-Pedersen B, et al. Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum[J]. Scand J Clin Lab Invest, 2004, 64(2) : 157-166.
  • 7Petereit HF, Bachmann G, Nekic M, et al. A new nephelometric assay for beta-trace protein (prostaglandin D synthase) as an indi- cator of liquorrhoea[ J]. J Neurol Neurosurg Psychiatry, 2001,71 (3) : 347-351.
  • 8Owen WE, Roberts WL. Performance characteristics of four immu- nonephelometric assays for the quantitative determination of IgA and IgM in cerebrospinal fluid[J]. Am J Clin Pathol, 2003, 119 (5) : 689-693.

共引文献13

同被引文献23

  • 1Baltimore RS, Shapiro ED. Pneumococcal infections [ M ]//Evans AS, Brachman PS. Bacterial infections of humans: epidemiology and control. 2 nd ed. NY: Plenum Medical Book Co, 1991 : 525- 546.
  • 2World Health Organization. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper[J]. Wkly Epidemi- ol Rec, 2007, 82(12): 93-104.
  • 3Rodgers GL, Klugman KP. The future of pneumococcal disease prevention[J]. Vaccine, 2011, 29 Suppl 3: C43- C48.
  • 4Audouy SA, van Selm S, van Ronsmalen ML, et al. Development of laetoeoccal GEM-based pneumoeoccal vaccines [ J ]. Vaccine, 2007, 25( 13): 2497-2506.
  • 5Tat SS. Streptocoecus ptteumoniae protein vaccine candidates: properties, activities and animal studies[J]. Crit Rev Mierobiol, 2006, 32(3) : 139-153.
  • 6Wu HY, Nahm MH, Guo Y, et al. Intranasal immunization of mice with PspA ( pneumococeal surface protein A ) (:an prevent in- tranasal carriage, pulmonary infection, and sepsis with Streptococcus pneamoniae[J]. J Irlfeet Dis, 1997, 175(4) : 839-846.
  • 7Moreno AT, Oliveira ML, Ferreira DM, et aL Immunization of mice with single PspA fragments induces antibodies capable of me- diating complement deposition on different pneumococcal strains aml emss-pratection[J]. Clin Vaccine lmmunol, 2010, 17(3 ) : 439-446.
  • 8Briles DE, Tart RC, Swiatlo E, et al. Pneumococcal diversity: considerations for new vaccine strategies with emphasis on poeumo- coccal surface protein A (PspA) [ J]. Clin Microbiol Rev, 1998, 11(4) : 645-657.
  • 9Hammerschmidt SI, Bethe G, Remane PH, et ah Identification nf pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pnettmoniae [ J ]. Infect Immun, 1999, 67 ( 4 ) : 1683-1687.
  • 10Hotomi M, Togawa A, Kono M, et al. PspA family distribution, antimicrobial resistance and serotype of Streptococcus paeumoniae isolated from upper respiratory tract infections in Japan [J]. PLoS One, 2013, 8(3) : e58124.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部